Bookmark and Share

Last Minute:          For more news, click here.

Remember me? 

Fall of
-0.76 (-0.93%%) SANOFI - [Ticker: SAN.PA]Chart SANOFI  News SANOFI  Download Historical Prices for Metastock SANOFI and Others  Technical Analysis SANOFI  
Last Trade80.53Last Trade Time2017-11-01 - 21:36:00
Variation-0.76 (-0.93%)Open81.79
Volume2,902,429Average Volume (3m)0
YieldBid / Ask71.12 x 1,000 - 71.74 x 44,000
Former Close81.2952 Week Range[0.00 - 0.00]
Ex-Dividend DateDividend Payment
Market Capitalization0 1 Year Price-Target0.00
Note: The data may have some minutes of delay.
Watch more quotes

Intraday   5 days   1 month   3 months   6 months   1 year   2 years   5 years   10 years            Use this chart on your website!
SANOFI -  [Ticker: SAN.PA] chart
Change to SANOFI Interactive Technical Analysis Chart

Last 10 Forum Topics about SANOFI:
No topics about SANOFI [SAN.PA] have been found, but a search on the Forum for more topics related to SANOFI is advised.

 News about SANOFI [SAN.PA]:   (ordered by relevance)
  1. Sanofi slumps as stagnation and litigation collide  Evaluate Pharma
  2. Sanofi, GSK, Haleon Lead $30 Billion Rout as Zantac Litigation Worries Mount  Bloomberg
  3. Reaction 'excessive' to Sanofi's upcoming litigation: analysts  FiercePharma
  4. GSK, Sanofi and Haleon 'facing billions of dollars in Zantac liability' -  pharmaphorum
  5. GSK, Sanofi and Haleon shares slump on Zantac litigation concerns  Reuters
Sanofi predicts pivot to high-value flu vaccines will drive another year of record sales Sanofi keeps its eye on the China prize with Innovent deal  Evaluate Pharma Sanofi halts recruitment for trials assessing MS treatment  PMLiVE Amid Roche and Sanofi's oral SERD setbacks, Menarini gets speedy review at FDA  Endpoints News Sanofi sells two portfolios of established products to Neuraxpharma Sanofi Lifts Forecast as Blockbuster Asthma Drug Gains  Bloomberg Sanofi appoints new Heads of U.S. General Medicines, and North America Vaccines and Consumer Healthcare  PR Newswire Sanofi Enters Oversold Territory (SNY)  Nasdaq Sanofi, Howard University partner on new diversity initiative  FierceBiotech Sanofi Down Nearly 8%, On Track for Largest Percent Decrease Since March 2020 ? Data Talk  Morningstar J&J lambasts Sanofi for Zantac marketing claims just as its Icy Hot pain patch campaign faces scrutiny  FiercePharma Sanofi : Media Update - Form 6-K Sanofi walks away from Regulus' kidney disease therapy  FierceBiotech GSK, Sanofi, Haleon Slump on Zantac Litigation Concerns - Latest Tweet by Reuters  LatestLY Sanofi: Arguably One Of The Most Undervalued Pharma Stocks (NASDAQ:SNY)  Seeking Alpha Sanofi and GSK Sink as Zantac Worries Wipe Out $40 Billion  msnNOW Second Innate Pharma NK Cell Engager Selected by Sanofi as Drug Candidate for Development  Business Wire EU, UK order 75 million COVID booster doses from Sanofi, GSK  EURACTIV China-based biotech licenses Sanofi's RNA drug technology  BioPharma Dive Sanofi and Regeneron announce positive phase 3 trial results for eosinophilic oesophagi in children under 12  PMLiVE Sanofi loses bid to revive case alleging a Viatris EpiPen monopoly  Reuters Amgen touts early combo data with Sanofi-backed KRAS partner in a bid to lift Lumakras' prospects  FierceBiotech Corporate Radar: Sanofi India to turn ex-dividend; Titan, M&M Q1 results; AGMs and more  Economic Times Deutsche Bank Sees Short Term Zantac Headwind for Sanofi (SNY) and Glaxo (GSK): 'we may see a liability of some $bn magnitude incurred' Sanofi Partners with Howard University for Unprecedented Pharmacy Fellowship Program  The Dig Sanofi India's Dividend Bounty Of 1930% Makes Investors Rich  Outlook India Sanofi (EPA:SAN) Stock Passes Above 200-Day Moving Average of $96.83  Defense World Health News Roundup: Africa CDC hopeful Aspen will get COVID vaccine orders; GSK, Sanofi and Haleon shares slump on Zantac litigation concerns and more  Devdiscourse Looking Into Sanofi's Recent Short Interest  Benzinga Sanofi India Ltd Spikes 3.35%  Business Standard Sanofi India, Paying 1930% Dividend, Will Turn Ex-Dividend Today  Goodreturns Sanofi (NASDAQ:SNY) Rating Lowered to Neutral at UBS Group  Defense World ISTH 2022 ? Sanofi faces more fitusiran doubts  Evaluate Pharma Sanofi scores a win with long-acting haemophilia project  Evaluate Pharma Sanofi moves further into next-gen oncology  Evaluate Pharma Sanofi makes another pipeline deal, tapping Adagene for antibody tech -  pharmaphorum Sanofi-GSK first to report a successful efficacy study against Omicron with COVID-19 Beta-containing vaccine  GSK Sanofi and GSK report 'positive' results from Covid booster  Financial Times Ash 2021 ? Sanofi takes its time with fitusiran  Evaluate Pharma Delays hit Sanofi  Evaluate Pharma Sanofi and Glaxo scrape a Covid vaccine latecomer  Evaluate Pharma Sanofi begins moving into big Boston HQ  FiercePharma Sanofi racks up 2 approvals in Europe for enzyme replacement therapies for rare diseases  FiercePharma EuroAPI gains on market debut after spin-off from Sanofi  Reuters Sanofi strikes $6bn antibody collaboration deal Sanofi furthers its digital ambitions with Paris accelerator -  pharmaphorum Works gets underway on new Sanofi vaccine facility in Singapore Regeneron purchases Sanofi's stake in Libtayo collaboration Sanofi and Exscientia establish strategic research collaboration  Drug Target Review Fitch Revises Sanofi's Outlook to Positive; Affirms at 'A+'  Fitch Ratings Sanofi to help fund healthcare systems in poor nations  FiercePharma Sanofi  FutureBrand Sanofi launches DE&I board with outside advisors, the first of its kind in pharma  FiercePharma Sanofi's CDMO spinoff set for next month as new group targets 2022 revenues of ?1B  FiercePharma Sanofi and McLaren Racing partner for manufacturing excellence  European Pharmaceutical Review Sanofi API spinout takes step toward market listing  BioPharma Dive Sanofi deploying $1B to turn France into 'pioneer mRNA nation'  FierceBiotech Sanofi pushes back expected Covid vaccine approval date again  Financial Times Next Gen: Sanofi's ambition to cut drug discovery by years  FierceBiotech Sanofi buoyed by blockbuster eczema drug Dupixent  Financial Times EUROAPI supports Sanofi's mRNA vaccine projects with lipid nanoparticle development Sanofi launches new funding foundation  PMLiVE Ash 2021 ? Sangamo and Sanofi enter the sickle cell gene editing fray  Evaluate Pharma Sanofi union members set strike date in Korea as wage negotiations stall: report  FiercePharma FDA pumps brakes on Sanofi's $3.7B multiple sclerosis bet  FierceBiotech Sanofi's simplified brand opens a fresh chapter as new strategy, pandemic help turn the page  FiercePharma Sign of the times: Sanofi unveils new logo  PharmaTimes Sanofi moves patients out of Ukraine warzone in 'Herculean effort' to preserve MS trials  FierceBiotech Sanofi launches new corporate brand and logo, and that goes for Genzyme and Sanofi Pasteur, too  FiercePharma Sanofi to pay up for epilepsy drug side effects  FiercePharma Sanofi cuts 2 dozen Kadmon staffers after $1.9B buyout  FiercePharma Sanofi offloads rights to prolonged-release antipsychotic drug  FiercePharma Sanofi isn't the only one clamoring for better flu shot guidance  FiercePharma On a roll, Sanofi raises Dupixent's peak sales target to ?13B-plus  FiercePharma Sanofi US forms digital therapeutics partnership with DarioHealth Sanofi Grants Regeneron Worldwide Exclusive License Rights to Libtayo  BioPharm International Long wait for pivotal data on Sanofi's oral SERD ends in failure  FierceBiotech Sanofi shares drop on trial setback for breast cancer pill  Reuters Ex-Sanofi CEO backs first European biomanufacturing SPAC -  pharmaphorum France's Sanofi offers 1.5 billion euro bond linked to access to medicine  Reuters Sanofi, Regeneron's Libtayo scores UK watchdog's approval in common form of skin cancer  FiercePharma Sanofi taps AI firm Yseop to automate trial report writing  FierceBiotech Sanofi snaps up Origimm for early-phase acne vaccine, opening new front in mRNA strategy  FierceBiotech Sanofi's Dupixent still 'at the beginning' of the journey: exec  FiercePharma Sanofi strikes $30M strategic agreement with digital health company DarioHealth  MedTech Dive Sanofi launches pharma's first Diversity, Equity & Inclusion Board  European Pharmaceutical Review Pressing for label change, vaccine giant Sanofi takes Seqirus influenza imbroglio to the FDA  FiercePharma Sanofi's latest analysis of Rezurock can inform future research, company says  FiercePharma Sanofi to Spend $1 Billion on Developing mRNA Vaccines in France  Bloomberg Sanofi acquires Translate Bio for mRNA therapeutic development  Drug Target Review Playing catch-up with J&J, Sanofi taps Blackstone for $300M to fund pivotal trial of subcutaneous Sarclisa  FiercePharma Sanofi Joins AI Gold Rush in ?4.6B Drug Discovery Pact with Exscientia JPM 2022: Sanofi has designs on creating Big Pharma's 'strongest' immunology franchise, CFO says  FiercePharma Rallybio inks deal with Sanofi for rare disease drug license  FierceBiotech Sanofi announces ?300m collaboration with Blackstone Life Sciences for multiple myeloma treatment Sanofi recognized by S&P as one of the most sustainability-committed companies  GlobeNewswire Sanofi pays IGM $150M, continuing search for better antibody drugs  BioPharma Dive Sanofi's net prices keep slipping?despite list price hikes?thanks to billions in rebates  FiercePharma Sanofi stock forecast: What?s next for SNY and SAN?
For more news about SANOFI click here:
Search the Internet:

Website Width:
Bookmark and Share

 Background image:

Copyright@2010-2022 -, all rights reserved.
Investment Forum Stock Quotes Investment News Investment Chat Disclaimer Webmaster Resources